您的当前位置:首页 > 行业数据 > Wegovy(24年)和Zepbound1年维持率超60%
图片属性
图片格式:PNG 图片大小:243KB 图片尺寸:1198*891
同报告图片
 / 4
Wegovy(24年)和Zepbound1年维持率超60%_第1页
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
Wegovy(24年)和Zepbound1年维持率超60%_第2页
Wegovy(24年)和Zepbound1年维持率超60%_第3页
Wegovy(24年)和Zepbound1年维持率超60%_第4页
Wegovy(24年)和Zepbound1年维持率超60%_第5页
所属报告: 【国金证券】医药行业研究:GLP-1专题,产品迭代驱动市场扩容,关注靶点、剂型及联合疗法研发进展-251117(38页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠